Business   

Japanese firm sues Dr. Reddy's

TOKYO NOV. 21. Eisai Co. Ltd, Japan's fourth-largest drug maker, said on Friday that it had filed lawsuits in New York against Dr. Reddy's Laboratories of India and Teva Pharmaceutical Industries of Israel alleging patent infringement.

Eisai said the action was in response to applications by the two firms to the U.S. Food and Drug Administration (FDA) to make a generic equivalent of Eisai's ulcer drug Aciphex. It said its U.S. patent on Aciphex is valid until May 8, 2013, and Dr. Reddy's and Teva had infringed it. Aciphex, which is classified as a proton pump inhibitor (PPI), had sales of 117 billion yen ($1.07 billion) globally in 2002-03, of which 88 per cent was in the U.S.

— Reuters

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Southern States | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts: Classifieds | Employment | Obituary |

Stories in this Section

• Govt. asks banks to pay interim dividends
• To hike FDI in private banks
• Asahi India plans unit in Chennai
• Curbs on ECBs: corporates feel the pinch
• Banks and risk-avoidance
• Amway's new initiative
• Maples' training programme
• NEC opens service centre
• BHEL bags Kuttiyadi project
• ISO 9001:2000 for Accel division
• Rupee recovers from early low
• Downtrend halted on BSE
• Telecom equipment makers seek level field
• SIAM splits over quadricycle
• PC units seek Crisil help
• Reliance Info launches intl. SMS
• Ranjana Kumar takes charge as Nabard chief
• Japanese firm sues Dr. Reddy's
• Bullion rates
• Exchange rates
• Stock Market Index

Copyright © 2003, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu